---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-026254"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:32:05.887396+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences Q1 revenue $6.8M (-11% YoY); net loss widens to $3.4M

## Summary
- Revenue $6.8M vs $7.6M YoY; global recurring revenue $4.7M (-10% YoY).
- Net loss $3.4M ($0.10 per share) vs $2.8M ($0.08) in Q1 2023.
- Gross margin fell to 46% from 58% YoY; operating expenses cut 14% to $6.0M.
- Domestic installed base: 907 XTRAC (down from 923 in Dec 2023); 104 TheraClear X (up from 92).
- Amended credit agreement with MidCap Financial; renewed 3-year exclusive distributor deals in China and Japan.

## SEC filing metadata
- accession: 0001140361-24-026254
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036124026254/0001140361-24-026254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036124026254/ef20029015_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-026254
- JSON: https://secwatch.observer/filing/0001140361-24-026254.json
- Plain text: https://secwatch.observer/filing/0001140361-24-026254.txt

## Key facts
- Earnings Releases
  STRATA Skin Sciences, Inc. reported the first fiscal quarter ended March 31, 2024 results: revenue $6.8 million, net income Net loss of $3.4 million, EPS net loss of $0.10 per basic and diluted common share.
  - Period: the first fiscal quarter ended March 31, 2024
  - Revenue: $6.8 million
  - Net income: Net loss of $3.4 million
  - EPS: net loss of $0.10 per basic and diluted common share
  - Result: reported results
  source text: announces its financial results for the quarter ended March 31, 2024 and provides a corporate update. First Quarter 2024 Highlights • Revenue in the first quarter of 2024 was $6.8 million (-11% YOY) vs. $7.6 million in the first quarter of 2023 o Global net recurring revenue in the first quarter of 2024 was $4.7 million (-10% YOY) vs. $5.2 million in the first
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000114036124026254/0001140361-24-026254-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.